AbCellera in COVID-19 antibody discovery pact with Eli Lilly
The two companies will partner to work on the discovery of nine antibodies, with the initial target being COVID-19-related.
The two companies will partner to work on the discovery of nine antibodies, with the initial target being COVID-19-related.
Sanofi will sell close to 23 million shares of Regeneron stock, with plans to use the funds to support acqusitions.
The company announces three deals on the same day, including an acquisition and two partnership deals against COVID-19.